Home Mainline IPOs Amwill Healthcare IPO
Orion Industries logo

Amwill Healthcare IPO

Open Sme
BSE 05 February - 07 February 2025
Amwill Healthcare Limited IPO is a book build issue of 59.98 Cr. The issue is a combination of fresh issue of 4403600 shares aggregating to 48.88 Cr and offer for sale of 1000000 shares aggregating to 11.1 Cr. Amwill Healthcare Limited IPO opened for subscription on Feb 05, 2025 and closed on Feb 07, 2025. The allotment for the this IPO was finalized on Feb 10, 2025. IPO was listed on NSE and BSE on Feb 12, 2025. Amwill Healthcare Limited IPO is set issue price band at ₹105 to ₹111 per share.

Current GMP

₹11 (+9.91%)

Price Band

₹ 105 – 111

Lot Size

1200

Issue Size

₹59.98 Cr

Minimum Investment

₹266400 (2400 Shares)

Listing Date

12 February 2025

Subscription

5.49x

About the Company

Amwill Healthcare Limited is a derma-cosmetic development company that focuses on creating dermatological, cosmeceutical, and aesthetic products. The company partners with contract manufacturers, distributors, and third-party development agencies to handle manufacturing, packaging, and distribution, enabling it to concentrate on product formulation and development. Its operations are concentrated in Karnataka, Andhra Pradesh, and Telangana, with plans to expand to West Bengal and Odisha.

The company’s product portfolio includes generic dermatological solutions and specialized formulations addressing specific skin problems. Amwill's products are developed with input from dermatologists, and its managing director, Anand Gandhi, has played a significant role in product development. The company has developed several products, though some were discontinued due to lack of market response.

Amwill collaborates with contract manufacturers to ensure quality compliance and leverages third-party developers for active ingredient preparation. Distribution is handled by Amderma Healthcare LLP, a promoter group entity that stores and delivers Amwill’s products to customers.

The company has a structured sales and marketing team, focusing on doctor relationships, exhibitions, and scientific journals to promote its products. The management team has over 20 years of experience in the dermatology industry, providing a competitive edge for the company's growth.

Financially, Amwill has shown significant growth, with a revenue increase from ₹1,799.94 lakhs in FY2021 to ₹3,578.83 lakhs in FY2023. Its EBITDA and profit after tax have also improved, indicating strong financial performance.

Promoters

  1. Anand Gandhi 
  2. Tarun Gandhi
Promoters Holding

Holding Pre Issue

97.00%

Holding Post Issue

0.00%

Objects of the Issue

The company proposes to utilize the Net Proceeds in the following manner.

  1. Funding of working capital requirements of the Company
  2. Marketing and brand-building activities
  3. General corporate purposes

Address / Contact Info

Amwill Healthcare Limited
No. 157, 1st Floor, 2nd Main, 3rd
Cross Chamrajpet, 
Bangalore – 560018, Karnataka

Phone: +91 8043026281
Email: amwill@amwillhealthcare.com
Website: https://www.amwillhealthcare.com/

IPO Snapshot

Face Value₹10 per share
Price Band₹ 105 – 111
Lot Size1200
Issue TypeBook-building IPO
Sale Type
Fresh Issue₹ 48.88 Cr
Offer for Sale₹ 11.10 Cr
Total Issue Size₹ 59.98 Cr
Listing AtBSE
Industry
Sector
QIB Quota0%
Retail Quota0%

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

Amwill Healthcare IPO is a Book-building IPO worth ₹59.98 crores. The price band is ₹105 to 111 per share. The IPO opens on Wed, Feb 5, 2025 and closes on Fri, Feb 7, 2025. It will be listed on BSE and NSE. Bigshare Services Pvt Ltd is the registrar.

The Amwill Healthcare IPO opens on Wed, Feb 5, 2025 and closes on Fri, Feb 7, 2025

Amwill Healthcare IPO Price Band is ₹105 to 111.

Amwill Healthcare IPO lot size is 1200, and the minimum amount required for application is ₹266400.

The minimum investment for Amwill Healthcare IPO is approximately ₹266400 based on the upper price band.

To apply for the Amwill Healthcare IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of Fri, Feb 7, 2025. After submission, funds are blocked until the basis of allotment of Amwill Healthcare IPO is finalised.

Amwill Healthcare IPO issue size is ₹59.98 crores.

Amwill Healthcare IPO allotment date is Sat, Jun 27, 2026.

The registrar for Amwill Healthcare IPO is Bigshare Services Pvt Ltd. Investors can go to Bigshare Services Pvt Ltd website for IPO allotment status, refund processing, and other queries related to Amwill Healthcare IPO through their official website or helpline.

The Amwill Healthcare IPO GMP (Grey Market Premium) is ₹3 as of Fri, Feb 7, 2025. Based on the upper price band of ₹111 per share, the estimated Amwill Healthcare IPO listing price is ₹114, indicating a potential listing gain of approximately 31% over the issue price.